Acquisition activities in Indian pharma sector : KKR & JB Chemicals agreement

Question : Which company has entered into an agreement to acquire 41.7 million equity shares of JB Chemicals ?
(a) KKR
(b) UBS
(c) Fidelity
(d) Vanguard group
Answer : (a)
Related facts

  • KKR has recently (July,2020) entered into an agreement to acquire 41.7 million equity shares of JB Chemicals, representing 54 per cent, from the promoters of the company.
  • After this transaction, an open offer will be launched to acquire 20.93 million fully paid-up equity shares of JB Chemicals, representing 26 per cent.
  • The open offer, too, is being made at a price of Rs 745 per share, said the company statement.
  • The deal size is estimated to be around $500 million (Rs 3,750 crore).
  • This is the second KKR investment in the past two months.
  • In May, it agreed to invest Rs 11,367 crore ($1.5 billion) in Reliance Industries’ digital assets subsidiary Jio Platforms to acquire 2.32 per cent stake — its largest investment in Asia to date.

KKR

  • KKR & Co. Inc. is an American global investment firm that manages multiple alternative asset classes, including private equity, energy, infrastructure, real estate, credit, and, through its strategic partners, hedge funds.

JB Chemicals

  • JB Chemicals that started as an API maker in the late Seventies owns some of the top brands in the Indian market — Rantac, Cilacar, and Metrogyl.
  • With a salesforce of around 2,000, it had a turnover of Rs 1,640 crore in 2019-20. It ranks among the top 40 companies in the domestic market.

By — Pankaj Pandey

Link:
https://www.business-standard.com/article/companies/kkr-to-acquire-controlling-stake-in-jb-chemicals-for-about-500-million-120070201917_1.html